PHARMING GRP SP. ADRS (PHG) — Cash Flow Reinvestment Rate
PHARMING GRP SP. ADRS (PHG) has a Cash Flow Reinvestment Rate of 0.05x as of December 2025, reinvesting €502.00K (capex €269.00K plus investments €233.00K) from operating cash flow of €10.71 Million. Explore PHARMING GRP SP. ADRS (PHG) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
PHARMING GRP SP. ADRS Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for PHARMING GRP SP. ADRS across 3 annual periods. Also explore PHARMING GRP SP. ADRS asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for PHARMING GRP SP. ADRS (2021–2025)
Year-by-year capital reinvestment analysis for PHARMING GRP SP. ADRS. For live market cap and broader valuation context, see PHARMING GRP SP. ADRS market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.57x | €85.98 Million | €54.71 Million | €755.00K | ▲ +1685.3% |
| 2022 | 0.09x | €1.98 Million | €22.46 Million | €1.98 Million | ▼ -84.4% |
| 2021 | 0.56x | €21.30 Million | €37.84 Million | €16.72 Million | — |